Hiroki Shimizu
Eisai Co., Ltd.
3
0
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Dylan Thompson, Dr.
University of Bath
Shared therapeutic areas:
Robert Chen, MD
University Health Network, Toronto
Shared therapeutic areas:
Jeongmin Kim
Severance Hospital, Yonsei University Health System
Shared therapeutic areas:
Duaa Almegbil
Jordan University of Science and Technology
Shared therapeutic areas:
Minoru Shinohara, Ph.D.
Georgia Institute of Technology
Shared therapeutic areas:
Narongkorn Saiphoklang, MD
Thammasat University Faculty of Medicine
Shared therapeutic areas:
Michael S Okun, MD
University of Florida
Shared therapeutic areas:
Maarten Kraan
Citryll BV
Shared therapeutic areas:
Fong-Chin Su
Chair Professor
Shared therapeutic areas:
Akira Endo
Drug Fostering and Evolution Coordination Department, Eisai Co., Ltd.
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects
A Bioequivalence Study of Film-coated Tablet and Dry Syrup 1% Form for E2020 in Healthy Japanese Adult Males
A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males
All 3 trials loaded